Ozempic and Mounjaro may also lower your risk of obesity-linked cancer
National Geographic (subscription required): Lindsey Wang, researcher at the School of Medicine, discussed her new research showing that weight-loss drugs such as Ozempic are linked to a lower risk of cancer. “This study mainly adds to the growing body of evidence that supports all these different beneficial effects of GLP-1 receptor agonists,” said Wang, noting that she conducted the research under the guidance of Distinguished University Professor Nathan Berger, who recently died at the age of 83.
